NFKB1 and cancer: It was observed that Sulindac metabolites inhibit NF-kB-mediated signals and have ROS mediating potential without inhibiting COX2 in cancer cell lines72, however, we observed inhibition of NF-kB and COX2 in various tissues in vivo along with increased expression of antioxidant genes.